Quality of life (QOL) results of the UK TACT2 trial: more intensive chemotherapy for early breast cancer (EBC) has a measurable impact on patient-reported symptoms and functioning (CRUK/05/019)
Authors
Velikova, GMorden, J
Barrett-Lee, P
Bloomfield, D
Brunt, M
Canney, P
Coleman, P
Russel, S
Verrill, M
Wardley, Andrew M
Bliss, J
Cameron, D
Affiliation
Leeds Institute of Cancer Studies and Pathology, University of Leeds, LeedsIssue Date
2015